Literature DB >> 20214219

Analysis of patients with rapid aggressive tumor progression of hepatocellular carcinoma after percutaneous radiofrequency ablation.

Kazue Shiozawa1, Manabu Watanabe, Masayoshi Takahashi, Noritaka Wakui, Kazunari Iida, Yasukiyo Sumino.   

Abstract

BACKGROUND/AIMS: Rapid aggressive tumor progression of hepatocellular carcinoma is one of the major complications after radiofrequency ablation. We statistically analyzed hepatocellular carcinoma patients with rapid aggressive tumor progression after radiofrequency ablation regarding patient characteristics, computed tomography findings, radiofrequency ablation methods, and the course of clinical and imaging changes and outcomes.
METHODOLOGY: We defined the tumor not detected by previous CT and US rapidly increased more than double in compared with the ablated area as rapid aggressive tumor progression. Ten hundred seventy three lesions of 538 patients underwent ultrasound-guided radiofrequency ablation in our hospital between April 1999 and March 2008. Of these patients, the risk factors for rapid aggressive tumor progression of 7 with 7 lesions were analyzed.
RESULTS: The rate of rapid aggressive tumor progression was 0.65%. Subcapsular lesions, a pretreatment Protein Induced by Vitamin K Absence-II level > or = 40mAU/ml, and initial treatment for hepatocellular carcinoma were significantly identified as risk factors.
CONCLUSIONS: There is possibility that portal vein invasion by hepatocellular carcinoma is an important factor involved in rapid aggressive tumor progression after radiofrequency ablation from the results of this study. In our opinion, these hepatocellular carcinomas need to be sufficiently ablated.

Entities:  

Mesh:

Year:  2009        PMID: 20214219

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  20 in total

1.  Heat Stress and Thermal Ablation Induce Local Expression of Nerve Growth Factor Inducible (VGF) in Hepatocytes and Hepatocellular Carcinoma: Preclinical and Clinical Studies.

Authors:  Scott M Thompson; Danielle E Jondal; Kim A Butters; Bruce E Knudsen; Jill L Anderson; Lewis R Roberts; Matthew R Callstrom; David A Woodrum
Journal:  Gene Expr       Date:  2018-07-04

2.  Effect of thermal dose on heat shock protein expression after radio-frequency ablation with and without adjuvant nanoparticle chemotherapies.

Authors:  Marwan Moussa; S Nahum Goldberg; Gaurav Kumar; Tatyana Levchenko; Vladimir Torchilin; Muneeb Ahmed
Journal:  Int J Hyperthermia       Date:  2016-09-06       Impact factor: 3.914

3.  Heat Stress and Hepatic Laser Thermal Ablation Induce Hepatocellular Carcinoma Growth: Role of PI3K/mTOR/AKT Signaling.

Authors:  Danielle E Jondal; Scott M Thompson; Kim A Butters; Bruce E Knudsen; Jill L Anderson; Rickey E Carter; Lewis R Roberts; Matthew R Callstrom; David A Woodrum
Journal:  Radiology       Date:  2018-05-08       Impact factor: 11.105

4.  Science to Practice: The Changing Face of Local Tumor Therapies-Do We Have to Think Systemically When Treating Cancer Locally?

Authors:  Julius Chapiro; Jean-François Geschwind
Journal:  Radiology       Date:  2015-08       Impact factor: 11.105

5.  The study of direct and indirect effects of radiofrequency ablation on tumor microenvironment in liver tumor animal model.

Authors:  An-Na Jiang; Bing Wang; Song Wang; Kun Zhao; Hao Wu; Kun Yan; Wei Wu; Wei Yang
Journal:  BMC Cancer       Date:  2022-06-17       Impact factor: 4.638

6.  Hepatic Radiofrequency Ablation-induced Stimulation of Distant Tumor Growth Is Suppressed by c-Met Inhibition.

Authors:  Muneeb Ahmed; Gaurav Kumar; Marwan Moussa; Yuanguo Wang; Nir Rozenblum; Eithan Galun; S Nahum Goldberg
Journal:  Radiology       Date:  2015-09-29       Impact factor: 11.105

7.  Hepatic radiofrequency ablation: markedly reduced systemic effects by modulating periablational inflammation via cyclooxygenase-2 inhibition.

Authors:  Gaurav Kumar; S Nahum Goldberg; Yuanguo Wang; Erik Velez; Svetlana Gourevitch; Eithan Galun; Muneeb Ahmed
Journal:  Eur Radiol       Date:  2016-06-10       Impact factor: 5.315

8.  Percutaneous cryoablation for perivascular hepatocellular carcinoma: Therapeutic efficacy and vascular complications.

Authors:  Ran Kim; Tae Wook Kang; Dong Ik Cha; Kyoung Doo Song; Min Woo Lee; Hyunchul Rhim; Hyo Keun Lim; Dong Hyun Sinn
Journal:  Eur Radiol       Date:  2018-07-24       Impact factor: 5.315

9.  In vivo detection of distal tumor glycolytic flux stimulated by hepatic ablation in a breast cancer model using hyperpolarized 13C MRI.

Authors:  J Scott Goodwin; Leo L Tsai; David Mwin; Patricia Coutinho de Souza; Svayam Dialani; John T Moon; Zheng Zhang; Aaron K Grant; Muneeb Ahmed
Journal:  Magn Reson Imaging       Date:  2021-04-24       Impact factor: 3.130

10.  Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation.

Authors:  Shuying Dong; Jian Kong; Fandong Kong; Jinge Kong; Jun Gao; Liang Ji; Bing Pan; Lian Chen; Lemin Zheng; Wenbing Sun
Journal:  BMC Cancer       Date:  2015-11-30       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.